| Serial Number | 86680065 |
| Word Mark | Q2 |
| Filing Date | Wednesday, July 1, 2015 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 31, 2019 |
| Registration Number | 5950382 |
| Registration Date | Tuesday, December 31, 2019 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, September 27, 2016 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the letter "Q" followed by a superscript number "2". |
| Goods and Services | Computerized database management and data processing services in the pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, medical device and diagnostics fields; providing business information, namely, information related to regulatory approval and marketing of drugs, devices, health care or medical products and services, and biologics; none of the foregoing for use in the field of Medicare |
| Goods and Services | Clinical research and testing services, in the fields of clinical trials, health care products, pharmaceutical products, pharmacogenomics products, biomarker products, biopharmaceutical products, medical devices and diagnostics products; product development consultation in the fields of health care, medical products and devices; health care research and product development services; medical and laboratory testing services for research purposes; laboratory testing services for research purposes in the fields of health care, clinical trials, pharmaceutical, pharmacogenomics, biomarker, biopharmaceutical, medical device and diagnostics; consultancy in the design, planning and implementation project management of clinical trials; health care medical research consultancy; product development consultancy in the fields of medical diagnostics, medical devices, pharmacology, pharmacogenomics, biomarkers and biopharmaceutical research; managing, namely, monitoring, coordinating and implementing clinical studies being clinical trials on human subjects for others for research purposes; medical and scientific research in the fields of healthcare and medical diagnostics; providing temporary use of non-downloadable, web-based software application for providing access to information and data in the clinical trials, pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, medical device and diagnostics, life sciences, health management and disease management fields and for organizing and analyzing said data and information and preparing reports therefrom,; providing temporary use of non-downloadable software for providing, managing and analyzing laboratory clinical trial data and information in the fields of pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, medical device and diagnostics, life sciences, health management and disease management fields; providing temporary use of non-downloadable software that allows remote access to clinical trial peri- and post-approval laboratory data and information; providing temporary use of non-downloadable software for use in collecting and reporting medical data relating to patient medical conditions for research; providing scientific and medical research information relating to the development and validation of drugs, pharmaceutical products, medical products, medical devices and biologics; providing an internet website portal featuring scientific and medical research information in the fields of clinical trials, pharmaceutical research, pharmacogenomic and biomarker consultation, biopharmaceutical consultation, medical devices and diagnostics, life sciences research, and medical research; providing an online searchable database via the internet featuring medical and scientific research information in the fields of clinical trials, companion diagnostics, pharmaceutical research, pharmacogenomic and biomarkers, biopharmaceuticals, medical devices and diagnostics, life sciences research, and medical research; all of the foregoing relating to clinical trials, clinical research, medical and scientific laboratory services, biopharmaceutical, biomarker, diagnostics and medical product and device development, and research, testing, regulatory approval and commercialization of diagnostics, biopharmaceuticals, biomarkers and medical products and devices and none of the foregoing for use in the field of Medicare or related to Medicare or other governmental health programs |
| Goods and Services | Providing health and medical information; providing pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing medical information relating to pharmacogenomics and biomarkers; health management and disease management medical information to others; medical evaluation services; medical consulting services in the fields of health care, medicine, life sciences, and pharmaceuticals, biopharmaceuticals, biomarkers, pharmacogenomics, medical device and diagnostics; providing an online interactive computer database in the field of healthcare featuring healthcare information; providing an Internet website portal featuring medical and healthcare information in the fields of medical services, health care, health management and disease management; providing an online searchable database via the internet featuring medical and healthcare information in the fields of medical services, medical devices and diagnostics, health care, health management and disease management; none of the foregoing for use in the field of Medicare |
| Goods and Services | Regulatory compliance research and consulting services in the fields of health care, clinical trials, development and testing of drugs, devices, biologics and methodologies used in the pharmaceutical industry, biotechnology industry and the medical device and diagnostics industry; consulting services in the fields of regulatory affairs, namely, regulatory compliance consulting in the field of prescription drug sampling; manufacturing compliance and validation procedures, namely, reviewing standards and practices to assure compliance with clinical trial regulations, medical and laboratory testing services; providing regulatory information, namely, providing regulatory compliance information regarding the examination and approval process of pharmaceutical, biotechnical, medical and diagnostic products and methodologies by governmental regulatory bodies; providing regulatory compliance consulting services relating to the development and validation of drugs, devices and biologics, namely, assisting others in implementing procedures that comply with regulatory requirements; none of the foregoing for use in the field of Medicare |
| Pseudo Mark | Q TWO |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 7, 2015 |
| Primary Code | 035 |
| First Use Anywhere Date | Sunday, March 31, 2019 |
| First Use In Commerce Date | Sunday, March 31, 2019 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 7, 2015 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, March 31, 2019 |
| First Use In Commerce Date | Sunday, March 31, 2019 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 7, 2015 |
| Primary Code | 044 |
| First Use Anywhere Date | Sunday, March 31, 2019 |
| First Use In Commerce Date | Sunday, March 31, 2019 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 7, 2015 |
| Primary Code | 045 |
| First Use Anywhere Date | Sunday, March 31, 2019 |
| First Use In Commerce Date | Sunday, March 31, 2019 |
| Party Name | Q Squared Solutions Holdings LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Morrisville, NC 27560 |
| Party Name | Q Squared Solutions Holdings LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Morrisville, NC 27560 |
| Party Name | Q Squared Solutions Holdings LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Morrisville, NC 27560 |
| Event Date | Event Description |
| Tuesday, December 31, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 26, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, November 25, 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, November 18, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, November 13, 2019 | USE AMENDMENT FILED |
| Wednesday, November 13, 2019 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, May 22, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 21, 2019 | EXTENSION 5 GRANTED |
| Friday, May 17, 2019 | EXTENSION 5 FILED |
| Tuesday, May 21, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, May 17, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, December 19, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Saturday, October 27, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 25, 2018 | EXTENSION 4 GRANTED |
| Thursday, October 25, 2018 | EXTENSION 4 FILED |
| Thursday, October 25, 2018 | TEAS EXTENSION RECEIVED |
| Wednesday, May 16, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, May 14, 2018 | EXTENSION 3 GRANTED |
| Monday, May 14, 2018 | EXTENSION 3 FILED |
| Monday, May 14, 2018 | TEAS EXTENSION RECEIVED |
| Thursday, November 9, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 7, 2017 | EXTENSION 2 GRANTED |
| Tuesday, November 7, 2017 | EXTENSION 2 FILED |
| Tuesday, November 7, 2017 | TEAS EXTENSION RECEIVED |
| Friday, May 12, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 10, 2017 | EXTENSION 1 GRANTED |
| Wednesday, May 10, 2017 | EXTENSION 1 FILED |
| Wednesday, May 10, 2017 | TEAS EXTENSION RECEIVED |
| Tuesday, November 22, 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 27, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 27, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 7, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, August 25, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, August 23, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, August 18, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, August 17, 2016 | ASSIGNED TO LIE |
| Wednesday, August 17, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 17, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 17, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, May 9, 2016 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, May 9, 2016 | FINAL REFUSAL E-MAILED |
| Monday, May 9, 2016 | FINAL REFUSAL WRITTEN |
| Saturday, April 16, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 15, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 15, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 20, 2015 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Tuesday, October 20, 2015 | PRIORITY ACTION E-MAILED |
| Tuesday, October 20, 2015 | PRIORITY ACTION WRITTEN |
| Monday, October 12, 2015 | ASSIGNED TO EXAMINER |
| Wednesday, July 8, 2015 | NOTICE OF PSEUDO MARK E-MAILED |
| Tuesday, July 7, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, July 4, 2015 | NEW APPLICATION ENTERED IN TRAM |